Indication

Bleeding episode in Glanzmann's thrombasthenia

A bleeding episode in Glanzmann's thrombasthenia refers to an acute hemorrhagic event occurring in individuals with Glanzmann's thrombasthenia, a rare, congenital, autosomal recessive platelet function disorder. Read more about Bleeding episode in Glanzmann's thrombasthenia

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Bleeding episode in Glanzmann's thrombasthenia therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Bleeding episode in Glanzmann's thrombasthenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bleeding episode in Glanzmann's thrombasthenia.

A bleeding episode in Glanzmann's thrombasthenia refers to an acute hemorrhagic event occurring in individuals with Glanzmann's thrombasthenia, a rare, congenital, autosomal recessive platelet function disorder.

The condition primarily impacts the hematologic system due to quantitative deficiency or qualitative dysfunction of the platelet membrane integrin alpha-IIb/beta-3 (glycoprotein IIb/IIIa), which prevents normal fibrinogen binding and impairs primary platelet aggregation despite normal platelet counts and morphology.

Clinically, these hemorrhagic episodes manifest predominantly as spontaneous or trauma-induced mucocutaneous bleeding, such as recurrent epistaxis, gingival hemorrhage, easy bruising, menorrhagia, or severe gastrointestinal bleeding, and can become life-threatening without prompt hemostatic control.

Personalize your experience

Follow Bleeding episode in Glanzmann's thrombasthenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it